Login / Signup

Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions.

Daniel Resende FaleirosEverton Nunes da SilvaAndreia C SantosBrian B GodmanRamon Gonçalves PereiraAugusto Afonso Guerra Junior
Published in: Expert review of pharmacoeconomics & outcomes research (2022)
This study demonstrates appreciable divergence (US$156.58 million) between the theoretical budget impact and RWE expenditures due to underestimated purchase prices and overestimated populations. The greater the degree of accuracy the more reliable and usable BIAs become for decision-making.
Keyphrases
  • decision making
  • electronic health record
  • smoking cessation